FOR IMMEDIATE RELEASE
Orthomolecular Medicine News Service, March 16, 2023

Millions of Avoidable Deaths from COVID-19

by Max Langen

OMNS (March 16, 2023) In the recent pandemic, a common reason many people died is the failure to use widely available, highly effective, safe, and inexpensive treatments that have proven to drastically reduce morbidity and mortality from this disease. Over the last several centuries and especially within the last decades, we have gained a huge amount of medical knowledge about biochemistry and nutrition -- and how important this is for maintaining a strong, resilient body and immune system. For example, cardiologist Dr. Thomas Levy wrote entire books that describe how extremely high dose vitamin C can treat or cure a wide spectrum of infectious diseases. [1] He cites more than 1,000 studies and reports from doctors and scientists who published lifesaving results from the use of nutrition supplements.

Too many people know nothing about these results. The problem is that those in the medical establishment who have the most power have interests other than health and welfare. They are interested in money and profits. Additional problems that may be responsible for the fact that millions of people have died unnecessarily from the pandemic include: ideologies, ignorance, a desire of control, unknowingness due to failure or unwillingness to consult other medical experts such as orthomolecular practitioners.

During the COVID-19-pandemic, those patients who got very sick from the viral illness and were thus hospitalized on average had a 13% (95% confidence interval: 9 to 17%) fatality rate. [2] However, a valuable successful early treatment protocol with synergistic combinations of cheap repurposed drugs and vitamins like the one from Dr. Fareed and Dr. Tyson (from California) proved to be safe in keeping almost all patients from being hospitalized. [3] Yet their protocol has been ignored, even though a study had confirmed that the thousands of patients who were treated early by those doctors had a 99.8% lower risk of death from COVID-19 than a control group comprising other patients from the same county. [3] They were ignored even after they informed the governments and health agencies about their excellent success rate. In addition to early treatment, they have also developed late treatment protocols. Those protocols have drastically reduced the risk of death of patients who were hospitalized (due to the failure to administer early treatment).

For example, in a blind random-controlled trial (RCT) that included 80 hospitalized COVID-patients, those who received, in addition to the standard treatment, a protocol consisting of vitamin D, vitamin C, zinc, selenium, magnesium, omega-3, l-arginine, l-glutamine, resveratrol, spirulina maxima, vegetable protein, folic acid, an intramuscular B-complex including: B1, B6 and B12 and probiotics (Saccharomyces boulardii) had a 57% lower risk of requiring mechanical ventilation and a 86% lower risk of death, compared with the patients who only received the standard treatment. [4] The control group had a mortality rate of 17.5%, consistent with the global C-19 hospital fatality rate, while the intervention group that received micronutrients, polyphenols, algae and probiotics had a mortality rate of only 2.5%.

Very likely, if the doses of vitamin C and vitamin D had been higher (and had vitamin D been given as calcifediol [5]), the mortality rate might have been even lower. Interestingly, a follow-up of all patients who survived found that those in the intervention group also had a 37% lower risk of Post-COVID-Syndrome than those who did not receive the nutritional support system. [4] Dozens of additional studies have also confirmed the high efficacy of many of these treatments (in isolated form) against COVID-19. [6-13]

One might imagine, after publication of studies showing a substantial drop in mortality from a nutritional support protocol, that a high dose combination of all these immune-relevant treatments would have been added to the standard of care in all countries, as early in their disease course as possible. Unfortunately, this was not widely done and people continued to die.

It was already clear from previous clinical studies with other infections, sepsis and other critical illnesses that these treatments are effective, have antiviral, anti-inflammatory, anticoagulant, cardioprotective effects, support the immune system, reduce the risk of infections and infectious complications, accelerate recovery and reduce mortality. Therefore, one might also imagine that COVID-19-patients would receive treatment with such synergistic protocols.

Examples of studies, most prior to 2020, showing the benefits of essential nutrients and other natural products in treatment of viral disease, pneumonia, and sepsis:

• Zinc: Meta-analyses of RCTs had shown that zinc supplementation accelerates the recovery of respiratory infections and reduces the risk of dying from severe pneumonia by 57%. [14,15]
• Vitamin D: A meta-analysis of RCTs had shown that daily or weekly vitamin D supplementation reduces the risk of respiratory infections, proving that it has direct or indirect antiviral/antibacterial effects and may thus also be effective for (early) treatment of infections. [16] Supplementation with vitamin D was shown in a placebo-controlled RCT to reduce the risk of dying from ventilator-associated pneumonia by 58%. [17] Also, vitamin D supplementation reduces the mortality rate of critically ill patients, as has been shown in a meta-analysis of seven RCTs and was later confirmed in a larger meta-analysis of sixteen RCTs, with parenteral administration showing higher efficacy than enteral. [18,19]
• Vitamin C: Meta-analyses of RCTs showed that vitamin C treatment reduces the length of stay in the intensive care unit (ICU) and the mortality rate of sepsis patients. [20,21] Many previous studies had shown that vitamin C (in higher than typical doses) shortens the duration of colds, helps overcome pneumonia, and reduces the mortality rate of tetanus patients. [22] The book Curing the Incurable from Dr. Levy summarizes more than 1,000 studies, showing how high dose vitamin C has been used successfully to cure many more infectious diseases and save patients' lives. [1]
• Omega-3 fatty acids: A meta-analysis of RCTs showed that omega-3 supplementation reduces the length of stay in the ICU and the duration of mechanical ventilation among septic patients. A clear trend towards reduced mortality was visible as well. [23] Another meta-analysis confirmed that omega-3 reduces the risk of death of patients with sepsis. [24] In addition to that, several RCTs had already shown that supplementation of omega-3 among hospitalized patients significantly reduces the risk of infections. [18] A meta-analysis of all these RCTs confirmed that omega-3 reduces the risk of hospital infections by 40%. [25]
  
  Also, some RCTs had already shown that treatment with omega-3 fatty acid supplements in the hospital setting significantly reduces the risk of developing sepsis, while several additional RCTs showed a reduced risk of developing sepsis. A meta-analysis that included all these studies showed that omega-3 reduces the risk of developing sepsis by 56%. [18] Further, a meta-analysis of RCTs showed that treatment with omega-3 also strongly improves the clinical outcomes of patients with acute respiratory distress syndrome (ARDS), including a lower ICU length of stay and shorter mechanical ventilation. [26]
• Spirulina: A interesting study showed that supplementation of the microalgae spirulina leads to a remarkable reduction of the viral load of HIV patients, improved immune health, and stopped infections like malaria. [27] Other studies confirmed that this algae has strong antioxidant, anti-inflammatory, immunomodulatory and non-specific antiviral effects. [28-30]
• L-Arginine: A meta-analysis of RCTs showed that supplementation of L-Arginine reduces the risk of infectious complications by 60%. [31]
• L-Glutamine: Meta-analyses of RCTs showed that treatment of critically ill patients with l-glutamine reduces the risk of infectious complications. [32,33] Interestingly, parenteral (IV) administration of l-glutamine was significantly effective, while enteral (stomach tube) administration only non-significantly reduced infectious complications. [32,34] Parenteral administration also reduced hospital mortality of critically ill patients. As a subgroup analysis of different dosages (unfortunately without distinguishing between parenteral or enteral) suggested, overall a dose between 300-500 mg per kg per day might be best. Higher doses (>0.5g per kg) might have negative effects. [33]
• Magnesium: Low magnesium levels promote inflammation, oxidative stress, coagulation, endothelial dysfunction, suppresses the immune system, and promotes the development of hypertension and diabetes. [35] Also, magnesium is required for the activation of vitamin D. Supplementation of magnesium improves endothelial function [35] and reduces the inflammatory biochemical C-reactive protein (CRP) among patients with elevated CRP, suggesting that it helps overcome chronic low-grade inflammation, one of the most important risk factors for severe COVID-outcomes. [36] Adequate magnesium levels can help to prevent high pressure [37], and can lower blood sugar and improve insulin-sensitivity in diabetics. [38]
  
  Other RCTs have shown that magnesium treatment may reduce coagulation and the risk of developing thrombosis. [39,40] In addition, magnesium is a very strong bronchodilator that helps to prevent dyspnea (shortness of breath, i.e. asthma). Chronic obstructive lung disease or asthma can be treated effectively with nebulized magnesium (spray), which improved the lung function and oxygen saturation and reduced the risk of hospitalization. [41,43] Given its mechanisms of action, magnesium is an important antidote to the COVID-19 disease. And given the fact that 90% of people in the US may have a magnesium deficiency, [35] this may have contributed to many deaths.
• Probiotics: Meta-analysis of RCTs has shown that supplementation of probiotics reduces the risk of developing pneumonia (among hospitalized patients) and upper respiratory infections. [43-45] Many different probiotic strains are available and in order to prevent or treat infections, specific effective strains or combinations of strains should be used. For the treatment of COVID-19, several different probiotic combinations have proven to be successful. [46] For example, a combination of Streptococcus thermophilus, L.acidophilus, L. helveticus, L. paracasei, L. plantarum, L. brevis, B. lactis, B. lactis has shown to be highly effective in studies, showing a 89% lower risk of respiratory failure with this probiotic treatment. [47]
• Resveratrol: Even though pre COVID-19, with regard to infections, only preclinical studies had been available for resveratrol, these studies showed very strong anti-inflammatory and antiviral effects. Based on these studies, it is likely effective against various infections including influenza, Epstein-Barr, herpes simplex, HIV, virulent pseudorabies, human metapneumovirus virus or enterovirus or poxviruses. [48-50] Also resveratrol has shown to inhibit infections with middle east respiratory syndrome coronavirus (MERS-Cov) infection. [51]
• Selenium: The fundamental role of selenium has also been known for a long time, because the immune system depends on it. It has antioxidant, immunomodulatory, anti-inflammatory and antiviral effects and promotes the production of antibodies. It supports the function of immune cells like natural killer cells. A deficiency of selenium exacerbates virulence and increases the risk of severe outcomes in case of viral infections, including a more serious lung pathology. [52] Selenium has shown to be effective against many different viral diseases, including HIV, influenza, hantavirus, and coxsackie virus. [53] Supplementation of selenium + zinc can reduce infections in older people who live in geriatric centers. [54]

A synergistic protocol like this could have been administered to all or most hospitalized patients (or better: to all outpatients, to prevent hospitalization) worldwide, since the beginning of the pandemic. Such a multi-micronutrient + plant extracts + algae + probiotic approach should have been part of the standard of care because it was known that the immune system can be supported by these measures. Given the knowledge provided by studies of supplementation of essential nutrients, isn't this obvious?

As of February 2023, globally, more than 7 million COVID-deaths had been reported. [55] How many millions of them would have survived, had a logical scientific approach, based on supplementation to empower the immune defense, been implemented worldwide from the outset?

Many authors, journalists, researchers, doctors and therapists, despite severe censorship, tried everything to reach the public and inform as many people as possible about effective treatments and about how to improve the immune system. Thanks to the work of all the platforms where this knowledge has been shared, many people were informed and lives saved. But many more still need to be reached. They also have the right to learn about these treatments, about how to improve and maintain (immune) health in reasonable, holistic ways, to be fit for future threats like infectious diseases. Given what we've learned from the study of essential nutrients empowering the immune system, we can do better.

Our health does not depend on the severely corrupted medical system that is focused on making huge profits from sick or frightened people rather than establishing and protecting health. The fact that the number of informed people is growing encourages me to be cautiously optimistic about the future of mankind.

(Max Langen has found that his own health problems were greatly alleviated by orthomolecular medicine. He is currently working on a book about it, and has plans to qualify as a therapist.)

References

1. Levy TE (2011) Curing the Incurable: Vitamin C, Infectious Diseases, and Toxins, 3rd Edition. Medfox Pub. ISBN-13: 978-0977952021

2. Alimohamadi Y, Tola HH, Abbasi-Ghahramanloo A, et al. (2021) Case fatality rate of COVID-19: a systematic review and meta-analysis. J Prev Med Hyg. 62:E311-E320. https://pubmed.ncbi.nlm.nih.gov/34604571

3. Tyson BM, Fareed G, Guiterrez EB, et al. (2022) Low rates of hospitalization and death in 4,376 COVID-19 patients given early ambulatory medical and supportive care. A case series and observational study. Substack preprint, https://c19hcq.org/tysonh.html

4. Leal-Martínez F, Abarca-Bernal L, García-Pérez A, et l. (2022) Effect of a Nutritional Support System to Increase Survival and Reduce Mortality in Patients with COVID-19 in Stage III and Comorbidities: A Blinded Randomized Controlled Clinical Trial. Int J Environ Res Public Health. 19:1172. https://pubmed.ncbi.nlm.nih.gov/35162195

5. Nogues X, Ovejero D, Pineda-Moncusí M, et al. (2021) Calcifediol Treatment and COVID-19-Related Outcomes. J Clin Endocrinol Metab. 106:e4017-e4027. https://pubmed.ncbi.nlm.nih.gov/34097036

6. Hosseini B, El Abd A, Ducharme FM. (2022) Effects of Vitamin D Supplementation on COVID-19 Related Outcomes: A Systematic Review and Meta-Analysis. Nutrients. 14:2134. https://pubmed.ncbi.nlm.nih.gov/35631275

7. Olczak-Pruc M, Swieczkowski D, Ladny JR, et al. (2022) Vitamin C Supplementation for the Treatment of COVID-19: A Systematic Review and Meta-Analysis. Nutrients. 14:4217. https://pubmed.ncbi.nlm.nih.gov/36235869

8. Tabatabaeizadeh SA. (2022) Zinc supplementation and COVID-19 mortality: a meta-analysis. Eur J Med Res. 27:70. https://pubmed.ncbi.nlm.nih.gov/35599332

9. Ceccarelli G, Borrazzo C, Pinacchio C, et al. (2021) Oral Bacteriotherapy in Patients With COVID-19: A Retrospective Cohort Study. Front Nutr. 7:613928. https://pubmed.ncbi.nlm.nih.gov/33505983

10. Sedighiyan M, Abdollahi H, Karimi E, et al. (2021) Omega-3 polyunsaturated fatty acids supplementation improve clinical symptoms in patients with COVID-19: A randomised clinical trial. Int J Clin Pract. 75:e14854. https://pubmed.ncbi.nlm.nih.gov/34516692

11. Cengiz M, Borku Uysal B, Ikitimur H, et al. (2020) Effect of oral l-Glutamine supplementation on COVID-19 treatment. Clin Nutr Exp. 33:24-31. https://pubmed.ncbi.nlm.nih.gov/32835086

12. Gibbons JB, Norton EC, McCullough JS, et al. (2022) Association between vitamin D supplementation and COVID-19 infection and mortality. Sci Rep. 12:19397. https://pubmed.ncbi.nlm.nih.gov/36371591

13. Mangge H, Prueller F, Dawczynski C, et al (2022) Dramatic Decrease of Vitamin K2 Subtype Menaquinone-7 in COVID-19 Patients. Antioxidants (Basel). 11:1235.

14. Hemilä H, Fitzgerald JT, Petrus EJ, Prasad A. (2017) Zinc Acetate Lozenges May Improve the Recovery Rate of Common Cold Patients: An Individual Patient Data Meta-Analysis. Open Forum Infect Dis. 4:ofx059. https://pubmed.ncbi.nlm.nih.gov/28480298

15. Wang L, Song Y. (2018) Efficacy of zinc given as an adjunct to the treatment of severe pneumonia: A meta-analysis of randomized, double-blind and placebo-controlled trials. Clin Respir J. 12:857-864. https://pubmed.ncbi.nlm.nih.gov/28488366

16. Martineau AR, Jolliffe DA, Greenberg L, et al. (2019) Vitamin D supplementation to prevent acute respiratory infections: individual participant data meta-analysis. Health Technol Assess. 23:1-44. https://pubmed.ncbi.nlm.nih.gov/30675873

17. Miroliaee AE, Salamzadeh J, Shokouhi S, Sahraei Z. (2018) The study of vitamin D administration effect on CRP and Interleukin-6 as prognostic biomarkers of ventilator associated pneumonia. J Crit Care. 44:300-305. https://pubmed.ncbi.nlm.nih.gov/29248753

18. Putzu A, Belletti A, Cassina T, et al. (2017) Vitamin D and outcomes in adult critically ill patients. A systematic review and meta-analysis of randomized trials. J Crit Care 38:109-114. https://pubmed.ncbi.nlm.nih.gov/27883968

19. Menger, J., Lee, ZY., Notz, Q. et al. (2022) Administration of vitamin D and its metabolites in critically ill adult patients: an updated systematic review with meta-analysis of randomized controlled trials. Crit Care 26:268. https://pubmed.ncbi.nlm.nih.gov/36068584

20. Hemilä H, Chalker E. (2019) Vitamin C Can Shorten the Length of Stay in the ICU: A Meta-Analysis. Nutrients. 11:708. https://pubmed.ncbi.nlm.nih.gov/30934660

21. Du X, Yang C, Yu X. (2019) [Effect of vitamin C on prognosis of critically ill patients: a Meta-analysis]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 31:942-948. Chinese. https://pubmed.ncbi.nlm.nih.gov/31537216

22. Hemilä H. (2017) Vitamin C and Infections. Nutrients 9:339. https://pubmed.ncbi.nlm.nih.gov/28353648

23. Lu C, Sharma S, McIntyre L, et al. (2017) Omega-3 supplementation in patients with sepsis: a systematic review and meta-analysis of randomized trials. Ann Intensive Care 7:58. https://pubmed.ncbi.nlm.nih.gov/28585162

24. Wang C, Han D, Feng X, Wu J. (2020) Omega-3 fatty acid supplementation is associated with favorable outcomes in patients with sepsis: an updated meta-analysis. J Int Med Res. 48:300060520953684. https://pubmed.ncbi.nlm.nih.gov/33373266

25. Pradelli L, Mayer K, Klek S, et al. (2020) ω-3 Fatty-Acid Enriched Parenteral Nutrition in Hospitalized Patients: Systematic Review With Meta-Analysis and Trial Sequential Analysis. JPEN J Parenter Enteral Nutr. 44:44-57. https://pubmed.ncbi.nlm.nih.gov/31250474

26. Langlois PL, D'Aragon F, Hardy G, Manzanares W. (2019) Omega-3 polyunsaturated fatty acids in critically ill patients with acute respiratory distress syndrome: A systematic review and meta-analysis. Nutrition 61:84-92. https://pubmed.ncbi.nlm.nih.gov/30703574

27. Ngo-Matip ME, Pieme CA, Azabji-Kenfack M, et al. (2015) Impact of daily supplementation of Spirulina platensis on the immune system of naïve HIV-1 patients in Cameroon: a 12-months single blind, randomized, multicenter trial. Nutr J. 14:70. https://pubmed.ncbi.nlm.nih.gov/26195001

28. Daoud HM, Soliman EM. (2015) Evaluation of Spirulina platensis extract as natural antivirus against foot and mouth disease virus strains (A, O, SAT2). Vet World 8:1260-1265. https://pubmed.ncbi.nlm.nih.gov/27047027

29. Chen YH, Chang GK, Kuo SM, et al. (2016) Well-tolerated Spirulina extract inhibits influenza virus replication and reduces virus-induced mortality. Sci Rep. 6:24253. https://pubmed.ncbi.nlm.nih.gov/27067133

30. Wu, Q., Liu, L., Miron, A. et al. (2016) The antioxidant, immunomodulatory, and anti-inflammatory activities of Spirulina: an overview. Arch Toxicol. 90:1817-1840. https://pubmed.ncbi.nlm.nih.gov/27259333

31. Kang K, Shu XL, Zhong JX, Yu TT. (2014) Effect of L-arginine on immune function: a meta-analysis. Asia Pac J Clin Nutr. 23:351-359. https://pubmed.ncbi.nlm.nih.gov/25164444

32. Wischmeyer PE, Dhaliwal R, McCall M, et al. (2014) Parenteral glutamine supplementation in critical illness: a systematic review. Crit Care 18, R76. https://pubmed.ncbi.nlm.nih.gov/24745648

33. Chen QH, Yang Y, He HL, et al. (2014) The effect of glutamine therapy on outcomes in critically ill patients: a meta-analysis of randomized controlled trials. Crit Care 18:R8. https://pubmed.ncbi.nlm.nih.gov/24401636

34. van Zanten, A.R.H., Dhaliwal, R., Garrel, D. et al. (2015) Enteral glutamine supplementation in critically ill patients: a systematic review and meta-analysis. Crit Care 19, 294. https://pubmed.ncbi.nlm.nih.gov/26283217

35. DiNicolantonio JJ, O'Keefe JH. (2021) Magnesium and Vitamin D Deficiency as a Potential Cause of Immune Dysfunction, Cytokine Storm and Disseminated Intravascular Coagulation in covid-19 patients. Mo Med. 118:68-73. https://pubmed.ncbi.nlm.nih.gov/33551489

36. Simental-Mendia LE, Sahebkar A, Rodriguez-Moran M, et al. (2017) Effect of Magnesium Supplementation on Plasma C-reactive Protein Concentrations: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Curr Pharm Des. 23:4678-4686. https://pubmed.ncbi.nlm.nih.gov/28545353

37. Zhang X, Li Y, Del Gobbo LC, Rosanoff A, et al. (2016) Effects of Magnesium Supplementation on Blood Pressure: A Meta-Analysis of Randomized Double-Blind Placebo-Controlled Trials. Hypertension. 68:324-333. https://pubmed.ncbi.nlm.nih.gov/27402922

38. Veronese N, Watutantrige-Fernando S, Luchini C, et al. (2016) Effect of magnesium supplementation on glucose metabolism in people with or at risk of diabetes: a systematic review and meta-analysis of double-blind randomized controlled trials. Eur J Clin Nutr. 70:1354-1359. https://pubmed.ncbi.nlm.nih.gov/27530471

39. Ruttmann TG, Montoya-Pelaez LF, James MF. (2007) The coagulation changes induced by rapid in vivo crystalloid infusion are attenuated when magnesium is kept at the upper limit of normal. Anesth Analg. 104:1475-1480. https://pubmed.ncbi.nlm.nih.gov/17513645

40. Shechter M, Merz CN, Paul-Labrador M, Meisel SR, et al. (1999) Oral magnesium supplementation inhibits platelet-dependent thrombosis in patients with coronary artery disease. Am J Cardiol. 84:152-156. https://pubmed.ncbi.nlm.nih.gov/10426331

41. Hossein S, Pegah A, Davood F, et al. (2016) The effect of nebulized magnesium sulfate in the treatment of moderate to severe asthma attacks: a randomized clinical trial. Am J Emerg Med. 34:883-886. https://pubmed.ncbi.nlm.nih.gov/26964827

42. Cömert Ş, Kıyan E, Okumuş G, et al. (2016) Kronik obstrüktif akciğer hastalığı enfektif alevlenmelerinde nebül magnezyum sülfatın etkinliği [Efficiency of nebulised magnesium sulphate in infective exacerbations of chronic obstructive pulmonary disease]. Tuberk Toraks. 64:17-26. Turkish. https://pubmed.ncbi.nlm.nih.gov/27266281

43. Liu KX, Zhu YG, Zhang J, et al. (2012) Probiotics' effects on the incidence of nosocomial pneumonia in critically ill patients: a systematic review and meta-analysis. Crit Care. 16:R109. https://pubmed.ncbi.nlm.nih.gov/22731894

44. Manzanares W, Lemieux M, Langlois PL, Wischmeyer PE. (2016) Probiotic and synbiotic therapy in critical illness: a systematic review and meta-analysis. Crit Care. 19:262. https://pubmed.ncbi.nlm.nih.gov/27538711

45. Zhao Q, Dong BR, Hao Q. (2022) Probiotics for preventing acute upper respiratory tract infections. Cochrane Database Syst Rev. 8:CD006895. https://pubmed.ncbi.nlm.nih.gov/36001877

46. Probiotics for COVID-19. (2023) COVID-19 early treatment. https://c19early.org/k

47. d'Ettorre G, Ceccarelli G, Marazzato M, et al. (2020) Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19. Front Med. (Lausanne). 7:389. https://pubmed.ncbi.nlm.nih.gov/32733907

48. Abba Y, Hassim H, Hamzah H, Noordin MM. (2015) Antiviral Activity of Resveratrol against Human and Animal Viruses. Adv Virol. 2015:184241. https://pubmed.ncbi.nlm.nih.gov/26693226

49. Zhao X, Tong W, Song X, et al. (2018) Antiviral Effect of Resveratrol in Piglets Infected with Virulent Pseudorabies Virus. Viruses. 10:457. https://pubmed.ncbi.nlm.nih.gov/30150559

50. Cao S, Realegeno S, Pant A, et al. (2017) Suppression of Poxvirus Replication by Resveratrol. Front Microbiol. 8:2196. https://pubmed.ncbi.nlm.nih.gov/29204136

51. Lin SC, Ho CT, Chuo WH, et al. (2017) Effective inhibition of MERS-CoV infection by resveratrol. BMC Infect Dis. 17:144. https://pubmed.ncbi.nlm.nih.gov/28193191

52. Bae M, Kim H. (2020) Mini-Review on the Roles of Vitamin C, Vitamin D, and Selenium in the Immune System against COVID-19. Molecules. 25:5346. https://pubmed.ncbi.nlm.nih.gov/33207753

53. Martinez SS, Huang Y, Acuna L, et al. (2021) Role of Selenium in Viral Infections with a Major Focus on SARS-CoV-2. Int J Mol Sci. 23:280. https://pubmed.ncbi.nlm.nih.gov/35008706

54. Girodon F, Lombard M, Galan P, et al. (1997) Effect of micronutrient supplementation on infection in institutionalized elderly subjects: a controlled trial. Ann Nutr Metab. 41:98-107. https://pubmed.ncbi.nlm.nih.gov/9267584

55. IHME COVID-19 Projections (2023) 7,727,905 reported COVID-19 deaths. https://covid19.healthdata.org/global

Nutritional Medicine is Orthomolecular Medicine

Orthomolecular medicine uses safe, effective nutritional therapy to fight illness. For more information: http://www.orthomolecular.org

Find a Doctor

To locate an orthomolecular physician near you: http://orthomolecular.org/resources/omns/v06n09.shtml

The peer-reviewed Orthomolecular Medicine News Service is a non-profit and non-commercial informational resource.

Editorial Review Board:

Albert G. B. Amoa, MB.Ch.B, Ph.D. (Ghana)
Seth Ayettey, M.B., Ch.B., Ph.D. (Ghana)
Ilyès Baghli, M.D. (Algeria)
Barry Breger, M.D. (Canada)
Ian Brighthope, MBBS, FACNEM (Australia)
Gilbert Henri Crussol, D.M.D. (Spain)
Carolyn Dean, M.D., N.D. (USA)
Ian Dettman, Ph.D. (Australia)
Susan R. Downs, M.D., M.P.H. (USA)
Ron Ehrlich, B.D.S. (Australia)
Hugo Galindo, M.D. (Colombia)
Gary S. Goldman, Ph.D. (USA)
Michael J. Gonzalez, N.M.D., D.Sc., Ph.D. (Puerto Rico)
William B. Grant, Ph.D. (USA)
Claus Hancke, MD, FACAM (Denmark)
Patrick Holford, BSc (United Kingdom)
Ron Hunninghake, M.D. (USA)
Bo H. Jonsson, M.D., Ph.D. (Sweden)
Dwight Kalita, Ph.D. (USA)
Felix I. D. Konotey-Ahulu, MD, FRCP, DTMH (Ghana)
Alan Lien, Ph.D. (Taiwan)
Homer Lim, M.D. (Philippines)
Stuart Lindsey, Pharm.D. (USA)
Pedro Gonzalez Lombana, MD, MsC, PhD (Colombia)
Victor A. Marcial-Vega, M.D. (Puerto Rico)
Juan Manuel Martinez, M.D. (Colombia)
Mignonne Mary, M.D. (USA)
Joseph Mercola, D.O. (USA)
Jorge R. Miranda-Massari, Pharm.D. (Puerto Rico)
Karin Munsterhjelm-Ahumada, M.D. (Finland)
Tahar Naili, M.D. (Algeria)
Zhiyong Peng, M.D. (China)
Isabella Akyinbah Quakyi, Ph.D. (Ghana)
Selvam Rengasamy, MBBS, FRCOG (Malaysia)
Jeffrey A. Ruterbusch, D.O. (USA)
Gert E. Schuitemaker, Ph.D. (Netherlands)
Thomas N. Seyfried, Ph.D. (USA)
Han Ping Shi, M.D., Ph.D. (China)
T.E. Gabriel Stewart, M.B.B.CH. (Ireland)
Jagan Nathan Vamanan, M.D. (India)

Andrew W. Saul, Ph.D. (USA), Editor-In-Chief
Associate Editor: Robert G. Smith, Ph.D. (USA)
Editor, Japanese Edition: Atsuo Yanagisawa, M.D., Ph.D. (Japan)
Editor, Chinese Edition: Richard Cheng, M.D., Ph.D. (USA)
Editor, Norwegian Edition: Dag Viljen Poleszynski, Ph.D. (Norway)
Editor, Arabic Edition: Moustafa Kamel, R.Ph, P.G.C.M (Egypt)
Editor, Korean Edition: Hyoungjoo Shin, M.D. (South Korea)
Editor, Spanish Edition: Sonia Rita Rial, PhD (Argentina)
Editor, German Edition: Bernhard Welker, M.D. (Germany)
Associate Editor, German Edition: Gerhard Dachtler, M.Eng. (Germany)
Assistant Editor: Michael Passwater (USA)
Contributing Editor: Thomas E. Levy, M.D., J.D. (USA)
Contributing Editor: Damien Downing, M.B.B.S., M.R.S.B. (United Kingdom)
Contributing Editor: W. Todd Penberthy, Ph.D. (USA)
Contributing Editor: Ken Walker, M.D. (Canada)
Technology Editor: Michael S. Stewart, B.Sc.C.S. (USA)
Associate Technology Editor: Robert C. Kennedy, M.S. (USA)
Legal Consultant: Jason M. Saul, JD (USA)

Comments and media contact: drsaul@doctoryourself.com OMNS welcomes but is unable to respond to individual reader emails. Reader comments become the property of OMNS and may or may not be used for publication.

To Subscribe at no charge: http://www.orthomolecular.org/subscribe.html

To Unsubscribe from this list: http://www.orthomolecular.org/unsubscribe.html